A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection

NCT00679497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: MVA-B
BIOLOGICAL: Placebo

Sponsor

Juan A. Arnaiz